Observational Study of Canadian Patients (6 Years or Older) Receiving Dupixent® for Moderate to Severe Atopic Dermatitis

NCT06099704 · clinicaltrials.gov ↗
COMPLETED
Status
305
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Sanofi

Collaborators